Cart
0
Product
Products
(empty)
No products
To be determined
Shipping
$0.00
Total
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart.
There is 1 item in your cart.
Total products
Total shipping
To be determined
Total
Data sheet
| Specificity | No detectable cross-reactivity with any other cytokine. |
| Sensitivity | < 5 pg/ml |
| Size | 96T |
| Storage | Store at 4 for frequent use, at -20 for infrequent use. |
| Expiration | Four months at 4 and eight months at -20. |
| Application | For quantitative detection of mouse OPG in serum, |
| Range | 93.8pg/ml-6000pg/ml |
More info
Product name
Mouse OPG ELISA Kit
Catalog No.
FM-E100112
Size
96T
Range
93.8pg/mL-6000pg/mL
Sensitivity
Less Than 5 pg/mL
Specificity
No detectable cross-reactivity with any other cytokine.
Storage
Store at 4 for frequent use, at -20 for infrequent use.
Avoid multiple freeze-thaw cycles (Shipped with wet ice.)
Expiration
Four months at 4 and eight months at -20.
Application
For quantitative detection of mouse OPG in serum,
body fluids, tissue lysates or cell culture supernates.
Kit Components
1. Lyophilized recombinant mouse OPG standard: 10ng/tube-2.
2. One 96-well plate precoated with anti- mouse OPG antibody.
3. Sample diluent buffer: 30 ml
4. Biotinylated anti- mouse OPG antibody: 130µL, dilution 1:100.
5. Antibody diluent buffer: 12ml.
6. Avidin-Biotin-Peroxidase Complex (ABC): 130µL, dilution 1:100.
7. ABC diluent buffer: 12ml.
8. TMB color developing agent: 10ml.
9. TMB stop solution: 10ml.
Background
Osteoprotegerin (OPG) is identical to osteoclastogenesis inhibitory factor (OCIF), a soluble member of the tumor-necrosis factor receptor family that inhibits osteoclastogenesis. OPG is considered to play an important role in the regulation of bone resorption by modifying osteoclast differentiation. Osteoprotegerin is an independent risk factor for the progression of atherosclerosis and onset of cardiovascular disease. It can act as a soluble factor in the regulation of bone mass and imply a utility for OPG in the treatment of osteoporosis associated with increased osteoclast activity. OPG system may play a critical role in the development of osteolytic bone disease in multiple myeloma and that targeting this system may have therapeutic potential. OPG also plays a role in the vascular system. The standard product used in this kit is recombinant OPG, a 100KDa glycoprotein.
Mouse OPG ELISA Kit-1X96 Well Plate Image